Speakers
Parallel session
Chair, Katharine Hayden
Norethisterone Interference in the Abbott Alinity Testosterone Assay, Chloe Ayre
Inter-Assay Variability of Neuron-Specific Enolase and Its Impact on Prognostic Thresholds Following Out-of-Hospital Cardiac Arrest, Amy Goodman
IGSF11 as a Biomarker of Adrenocortical Normality: Distinguishing Malignant from Non-Malignant Adrenocortical Tumours, Anila Hashmi
Are Kappa Free Light Chains and the Index a Reliable Alternative Biomarker to Oligoclonal Banding for Diagnosis of Multiple Sclerosis? Marie Clarke
Untargeted metabolomics as a diagnostic tool for inherited metabolic disease: A case series of five disorders, Greg Toulson
Kath Hayden is a Consultant Clinical Biochemist at Manchester University NHS Foundation Trust and Honorary Senior Lecturer at the University of Manchester.
Following training in South Manchester, Kath has held posts in hospitals in Manchester and Liverpool over a 35 year period, overseeing significant advances in analytical technologies, point of care testing (POCT) and harmonisation of laboratories. With specialist interests in endocrinology, POCT, leadership and service improvement, her latest roles have been as Clinical Head of Division for Laboratory Medicine at Manchester University NHS Foundation Trust, Trust Lead Healthcare Scientist, Clinical Director for Laboratory Medicine and Head of Service for Clinical Biochemistry at Central Manchester University Hospitals NHS Foundation Trust.
Pronouns: She/her